Celiac Support Association

Digestive Disease Week 2015

Washington, DC

Of interest to those with Gluten Related Disorders

Click here to find online abstracts provided at Digestive Disease Week.


 

Saturday May 16

Oral Presentation

• Direct Costs in Patients With Celiac Disease - A Retrospective Claims Analysis  

• Presentation: #108

Title: Widespread Contamination of Probiotics with Gluten, Detected by Liquid Chromatography-Mass Spectrometry

Authors: Samantha Nazareth1 , Benjamin Lebwohl1 , Jennifer Sealey Voyksner2 , Peter H. Green1 

1 Columbia/NY-Presbyterian, New York, New York, United States; 2 ImmunogenX, Pittboro, North Carolina, United States

One reason cited for this study out of Columbia University, was that University doctors noted that approximately 24% of their celiac patients who were taking supplements were experiencing more celiac related symptoms than those who were not taking supplements.  That prompted the researchers involved in this study to analyze the gluten content of 22 popular probiotics.  Probiotics are among one of the most popular supplements celiac patients take.  

Look for an in-depth follow-up article, written by CSA’s Chief Medical Advisor, Anthony Colatrella, MD, coming out in the next CSA member-based LIFEline newsletter.

 

Saturday Poster Sessions 9:30AM- 4PM

Celiac Disease: Basic

Celiac Disease: Clinical

  • Sa1275: The Diagnostic Delay in Celiac Disease is Significantly Increased in Women Due to Doctor’s but not Patient’s Delay
  • Sa1276: The Perspective of Celiac Disease Patients on Emerging Treatment Options and Non-Celiac Gluten Sensitivity
  • Sa1277: Functional gastrointestinal symptoms in patients with celiac disease: Prevalence at diagnosis and response to a gluten free diet
  • Sa1278: Assessing the Genetic Susceptibility for Celiac Disease in a Racially/Ethnically Diverse Population: A Retrospective Chart Review of Patients Undergoing HLA-DQ Testing for Solid Organ Transplant
  • Sa1279: Short-Term Progression of Histology in Indian Patients with Potential Celiac Disease
  • Sa1280: The Gluten-Free Diet Alone Does Not Control Symptoms and Mucosal Injury in Many Patients with Celiac Disease
  • Sa1282: Attitudes toward genetic testing for celiac disease
  • Sa1283: Prevalence of Comorbidities in Patients With Celiac Disease
  • Sa1284: Effects of adherence to gluten-free diet on quality of life in adult celiac disease patients.
  • Sa1285: Candidates for Celiac Disease Diagnosis Go Untested: a Preliminary Report from a Case-Control Study

9:30am-4:00pm Sat, May 16

  • Sa1286: Vaccination Outcomes in Celiac Disease
  • Sa1287: COMPARISON BETWEEN ANTI-TRANSGLUTAMINASE SERUM LEVELS AND THE DEGREE OF DUODENAL LESIONS: IDENTIFICATION OF A THRESHOLD VALUE USEFUL TO THE SERODIAGNOSIS OF CELIAC DISEASE IN ADULTS
  • Sa1288: Pancreatic Exocrine Insufficiency in Adult Patients with Celiac Disease: Is it due to structural alterations in pancreatic parenchyma?
  • Sa1289: Isolated elevation of DGP IgA antibodies: lack of predictive value for diagnosing celiac disease
  • Sa1290: Risk of celiac disease in the first and second degree relatives of patients with celiac disease: A meta-analysis
  • Sa1292: Concomitant Celiac Disease Does not Modify the Response to Treatment with Bismuth Subsalicylate in Patients with Microscopic Colitis
  • Sa1293: Endoscopic appearance correlates poorly with serology and histology in celiac patients on a gluten-free diet
  • Sa1294: Lymphocytic Gastritis in Patients with Celiac Disease; Increasing Prevalence According to Age and Severity of Villous Atrophy
  • Sa1295: Reflux symptoms in patients with celiac disease are associated with alkaline or weakly acid reflux
  • Sa1296: Duodenal Eosinophilia in Celiac Disease and Functional Dyspepsia – A Marker for Wheat Sensitivity?
  • Sa1297: The Degree of Mucosal Damage to the Small Intestine and Serum IgG4 Levels Correlate with Celiac Disease
  • Sa1298: Perceived wellbeing in celiac disease; association with patient reported outcomes, clinical indices and biologic parameters.
  • Sa1301: HIGH RATES OF PRIOR CELIAC DISEASE OVERDIAGNOSIS AMONG PATIENTS REFERRING TO AN ITALIAN TERTIARY CARE CENTER
  • Sa1302: Delay in diagnosis of celiac disease in patients without gastrointestinal complaints
  • Sa1304: Bone Mineral density in Celiac Disease
  • Sa1306: Point of care testing for celiac disease in patients presenting to endoscopy with anemia
  • Sa1307: Comparison of three commercially available point of care tests for celiac disease
  • Sa1308: Predicting histological remission in patients with celiac disease on a gluten-free diet
  • Sa1310: Is the response to Hepatitis B vaccine different in adult Celiac Disease ?
  • Sa1311: Early recognition of possible pitfalls in histological diagnosis of celiac disease
  • Sa1767: Alkylresorcinols, Indicator for Gluten Consumption in Celiac Disease Patients
  • Sa1768: IN THE INTESTINAL MUCOSA OF CHILDREN WITH POTENTIAL CELIAC DISEASE IL-21 IS LESS EXPRESSED THAN IN THE ACTIVE DISEASE
  • Sa1770: Structural and functional changes in the tight junctions of asymptomatic and serology negative first-degree relatives of patients with celiac disease
  • Sa1772: ILC-like lymphomas in refractory celiac disease type II respond to multiple common γ-chain cytokines and are sensitive to JAK-inhibitors
  • Sa1773: Reduced T-Cell receptor variability in refractory celiac disease type II as revealed by next generation sequencing
Celiac And Non-Celiac Gluten Sensitivity: Diagnosis, Management And Monitoring (L104)

107: RESULTS FROM THE 'GLUTOX' TRIAL: A RANDOMISED, DOUBLE BLIND, PLACEBO CONTROLLED CROSSOVER STUDY ON 'NON CELIAC GLUTEN SENSITIVITY'

Sunday, May 17 2015

  •  251: Celiac Disease histopathology recapitulates Hedgehog down regulation and is consistent with activation of wound healing process in the lamina propria
  •  Su1065: Fluctuating Celiac Disease Related Autoimmunity in the Elderly Screened for Celiac Disease
  • Su1288: Patients with Coexistent Celiac Disease and Inflammatory Bowel Disease Have Distinct Phenotypic Patterns
  • Su1397: Very Low and Similar Proportions of Patients with Celiac Disease Among Patients with Normal and Elevated ALT Levels, Especially Among Non-Whites: Results of a U.S. Nationwide Sample of 16,795 persons

Monday, May 18 2015

 Celiac Disease vs. Gluten Intolerance (FC04)        Ticketed Breakfast
  • Mo1176: Pandora’s box: Coeliac Disease among first-degree relatives of screening-detected celiac patients
  • Mo1186: Are Duodenal Biopsies Necessary For The Diagnosis Of Celiac Disease In Diabetes Mellitus Type 1 Patients With Positive Serology
  • Mo1194: The Effect of a Gluten-Free Diet on Growth Velocity in Childhood Celiac Disease
  • Mo1217: Exploring the Immunologic Evolution in the Pre-Clinical Stage of Celiac Disease
  • Mo1592: Prospective study of narrow band imaging-based evaluation of duodenal villous morphology in patients with and without celiac disease
  • Mo1611: Double balloon-assisted deep enteroscopy for the study of patients suspected of complicated celiac disease.
Does This Patient Really Have Celiac Disease? (CC03)
Celiac Disease – Which Factors Are At Play in Childhood That Can Increase the Risk To Develop the Disease in Adulthood?
  • Sp679: How HLA Haplotype Can Influence the Risk of Developing Celiac Disease
  • Sp680: Timing of Gluten Introduction and Risk of Celiac Disease
  • Sp681: Preventing Celiac Disease
  • Sp682: The Role of Gut Microbiome and Metabolome in the Onset of Celiac Disease in Genetically At-Risk Individuals
  • Sp655: Duodenum: Celiac Disease and Autoimmune Enteropathy
  • Celiac Disease: Causes and Dilemmas
  • Sp723: Why Is Celiac Disease on the Rise, and Can It Be Prevented?
  • Sp724: Suspected Celiac Disease: How to Secure a Diagnosis?
  • 780: Bio-accumulating Metal Levels in Celiac Patients and Individuals on a Gluten-Free Diet
  • Sp726: How To Diagnose and Manage Refractory Celiac Disease?
The annual meeting of the North American Society for the Study of Celiac Disease (NASSCD) 6:45 p.m. on Monday, May 18, in Room 156 of the Walter E. Washington Convention Center. 

Tuesday, May 19 2015

Updates on the Diagnosis of Celiac Disease
  • Sp820: Overview Discussion: New Developments in Diagnosing and Assessing Celiac Disease
  • 846: Cost-Effectiveness of Routine Duodenal Biopsy for Celiac Disease Screening in Patients Undergoing Endoscopy for the Evaluation of Refractory Gastroesophageal Reflux
  • 847: Evaluation of antibodies to cytolethal distending toxin B (CdtB) and vinculin in celiac disease
  • 849: Gamma-Delta T-Lymphocytes as diagnostic criterium in latent celiac disease
  • 850: Anti-tissue transglutaminase autoantibody levels predict histology in celiac disease: a prospective application of the ESPGHAN guidelines in a symptomatic adult population.
  • Tu1214: Should video capsule endoscopy (VCE) be utilized in the evaluation of celiac patients with persistent symptoms?
  • Tu1750: High definition (HD) endoscopy but not I-Scan significantly increases the detection of markers of celiac disease: A multicentre UK study

 

 

Amazon Logo